Freshfields-Led Drug Co. To Buy Forte Biosciences For $2.2B
Belgian-Dutch pharma company Argenx SE said Monday that it has agreed to acquire Forte Biosciences Inc. for approximately $2.2 billion, building on its existing investment in the U.S. company....To view the full article, register now.
Already a subscriber? Click here to view full article